Cargando…

Phenytoin-induced changes in the pharmacokinetics of misonidazole in radiotherapy patients.

Detalles Bibliográficos
Autores principales:	Moore, J. L., Paterson, I. C., Newman, H., Venables, S.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1981
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010798/ https://www.ncbi.nlm.nih.gov/pubmed/7295516

Ejemplares similares

Effects of pretreatment with phenobarbitone and phenytoin on the pharmacokinetics and toxicity of phenytoin on the pharmacokinetics and toxicity of misonidazole in mice.
por: Workman, P.
Publicado: (1979)

The effect of phenytoin, phenobarbitone, dexamethasone and flurbiprofen on misonidazole neurotoxicity in mice.
por: Sheldon, P. W., et al.
Publicado: (1984)

The role of dexamethasone in the modification of misonidazole pharmacokinetics.
por: Jones, D. H., et al.
Publicado: (1983)

Phenytoin shortens the half-life of the hypoxic cell radiosensitizer misonidazole in man: implications for possible reduced toxicity.
por: Workman, P., et al.
Publicado: (1980)

Pharmacokinetic rationale for the interaction of 5-fluorouracil and misonidazole in humans.
por: McDermott, B. J., et al.
Publicado: (1983)

Effects of local hyperthermia on the pharmacokinetics of misonidazole in the anaesthetized mouse.
por: Honess, D. J., et al.
Publicado: (1980)

Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice.
por: Lee, F. Y., et al.
Publicado: (1983)

In vitro metabolism of misonidazole.
por: Josephy, P. D., et al.
Publicado: (1981)

Bleomycin and misonidazole cytotoxicity.
por: Korbelik, M., et al.
Publicado: (1985)

A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma.
por: Bleehen, N. M., et al.
Publicado: (1981)

Oxygen dependence for chemosensitization by misonidazole.
por: Roizin-Towle, L., et al.
Publicado: (1986)

Misonidazole and CCNU: further evidence for a pharmacokinetic mechanism of chemosensitization and therapeutic gain.
por: Lee, F. Y., et al.
Publicado: (1984)

Split dose cytotoxic experiments with misonidazole.
por: Stratford, I. J.
Publicado: (1978)

Effects of Carbamazepine and Phenytoin on Pharmacokinetics and Pharmacodynamics of Rivaroxaban
por: Ngo, Lien Thi, et al.
Publicado: (2020)

Microscopic distribution of misonidazole in mouse tissues.
por: Cobb, L. M., et al.
Publicado: (1989)

Chemopotentiation of CCNU metabolites by misonidazole.
por: Mulcahy, R. T.
Publicado: (1985)

The penetration of misonidazole into spontaneous canine tumours.
por: White, R. A., et al.
Publicado: (1979)

Factors influencing the chemosensitization of melphalan by misonidazole.
por: Randhawa, V. S., et al.
Publicado: (1985)

INFLUENCE OF SPIRULINA ON THE PHENYTOIN INDUCED HAEMATOLOGICAL CHANGES
por: Thaakur, Santh Rani, et al.
Publicado: (2007)

Influence of misonidazole on the incidence of radiation-induced intestinal tumours in mice.
por: Rostom, A. Y., et al.
Publicado: (1978)

Studies with bleomycin and misonidazole on aerated and hypoxic cells.
por: Roizin-Towle, L., et al.
Publicado: (1978)

Hypoxic cells and in situ chemopotentiation of the nitrosoureas by misonidazole.
por: Wheeler, K. T., et al.
Publicado: (1984)

Phenytoin induced chorea in a pediatric patient: An interaction between phenytoin, phenobarbital and clobazam
por: Barvaliya, Manish, et al.
Publicado: (2011)

Is tumour radiosensitization by misonidazole a general phenomenon?
por: Denekamp, J., et al.
Publicado: (1980)

Effect of misonidazole on radiation injury to mouse spinal cord.
por: Travis, E. L., et al.
Publicado: (1982)

Modulation of the hypoxic toxicity and binding of misonidazole by glucose.
por: Ling, L. L., et al.
Publicado: (1986)

Quantitative cytochemical assessment of the neurotoxicity of misonidazole in the mouse.
por: Clarke, C., et al.
Publicado: (1982)

Chemosensitization by misonidazole in CCNU-treated spheroids and tumours.
por: Durand, R. E., et al.
Publicado: (1987)

Peripheral electrophysiological parameters in mice treated with misonidazole.
por: Von Burg, R., et al.
Publicado: (1979)

The penetration of misonidazole into a mature structural cartilage.
por: Langler, A. J., et al.
Publicado: (1982)

The quantitative response of human tumours to radiation and misonidazole.
por: Ash, D. V., et al.
Publicado: (1979)

The effects of melphalan and misonidazole on the vasculature of a murine sarcoma.
por: Murray, J. C., et al.
Publicado: (1987)

Phenytoin Pharmacokinetics During Venoarterial Extracorporeal Membrane Oxygenation and Plasma Exchange
por: Osborne, Joseph C, et al.
Publicado: (2021)

Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain.
por: Hirst, D. G., et al.
Publicado: (1982)

Oncogenic transformation in vitro by the hypoxic cell sensitizer misonidazole.
por: Miller, R. C., et al.
Publicado: (1978)

Pharmacodynamic and pharmacokinetic interaction of Panchagavya Ghrita with phenytoin and carbamazepine in maximal electroshock induced seizures in rats
por: Joshi, Rupa, et al.
Publicado: (2015)

Pharmacokinetic Behavior of Phenytoin in Head Trauma and Cerebrovascular Accident Patients in an Iranian Population
por: Alimardani, Shahnaz, et al.
Publicado: (2017)

A biochemical method for assessing the neurotoxic effects of misonidazole in the rat.
por: Rose, G. P., et al.
Publicado: (1980)

Dependence of misonidazole binding on factors associated with hypoxic metabolism.
por: Ling, L. L., et al.
Publicado: (1987)

In vivo combination of misonidazole and the chemotherapeutic agent CCNU.
por: Siemann, D. W.
Publicado: (1981)

Cannot write session to /tmp/vufind_sessions/sess_3c63p47p0evf8q3etopilshhk4